MFBTD
REGN icon

MB Financial Bank - Trust Department’s Regeneron Pharmaceuticals REGN Stock Holding History

MB Financial Bank - Trust Department’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-20
Closed -$9K – 615
2015
Q3 		$9K Hold
20
– – ﹤0.01% 376
2015
Q2 		$10K Hold
20
– – ﹤0.01% 371
2015
Q1 		$9K Hold
20
– – ﹤0.01% 356
2014
Q4 		$8K Hold
20
– – ﹤0.01% 389
2014
Q3 		$7K Buy
+20
New +$6.7K ﹤0.01% 511

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

MB Financial Bank - Trust Department's REGN Position: Q4 2015 in Review

MB Financial Bank - Trust Department sold out of Regeneron Pharmaceuticals (REGN) in Q4 2015, closing a stake of 20 shares — an estimated $9K sold.

MB Financial Bank - Trust Department first reported a position in REGN in Q3 2014 and held it in 5 quarters. The position peaked at $10K in Q2 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

  • MB Financial Bank - Trust Department reported no remaining Regeneron Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • MB Financial Bank - Trust Department sold 20 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $9K.
  • MB Financial Bank - Trust Department first reported a position in Regeneron Pharmaceuticals in Q3 2014 and held it in 5 quarters.
  • MB Financial Bank - Trust Department's Regeneron Pharmaceuticals position peaked at $10K in Q2 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on MB Financial Bank - Trust Department's 13F filing for Q4 2015, filed 7 Jan 2016.